RE:RE:RE:RE:RE:RE:RE:RE:If I could run 5X faster than the competition... "I'll be voting NO on the merger and later in the AGM as well."
Show us the expected cash at the end of Q1 and the best way forward given the costs of the avenanthramide clinical trial, the simultaneous 5X/10X PGX scale-up and need to support a potential PGX partnership, the need for money for the fibrosis trial, and for a wound healing partnership. Where is the money coming from for a $40 million PGX-YBG plant for an immune booster if that is a priority? Ronnie Miller says that after careful consideration this merger is the best way forward. Bloom Burton provided a fairness opinion. Gilles is an insider at CZO and AEZS and is posiitoned better than anyone. What information do you have that this isn't the best way forward as stated by Ronnie Miller who was President and CEO of Roche Canada? Where are you going to get $50 million cash, the potential diagnostic cash cow, the tax loss carryforwards, and the other assets. Do you want to try a $40 million finanicng with warrants?
“We are thrilled with this exciting transaction to merge with Aeterna and combine two complementary companies and teams, in support of our plan to drive significant growth,” said Ronnie Miller, Chairman of Ceapro. “After careful consideration, we believe this transaction is the best way forward for Ceapro and our valued shareholders.” news release